HuGE Literature Finder
Records
1
-
22
| A Population Pharmacokinetic Meta-Analysis of Veliparib, a PARP Inhibitor, Across Phase 1/2/3 Trials in Cancer Patients. Journal of clinical pharmacology 2021 Apr . Stodtmann Sven, Nuthalapati Silpa, Eckert Doerthe, Kasichayanula Sreeneeranj, Joshi Rujuta, Bach Bruce A, Mensing Sven, Menon Rajeev, Xiong H |
| Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients with Depression. Therapeutic drug monitoring 2020 Dec . Komahashi-Sasaki Hazuki, Yasui-Furukori Norio, Sasaki Taro, Shinozaki Masataka, Hayashi Yuki, Kato Kazuko, Inoue Yoshimasa, Tsuchimine Shoko, Watanabe Takashi, Sugawara Norio, Shimoda Kazuta |
| Model-Based Quantification of Impact of Genetic Polymorphisms and Co-Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer. Clinical pharmacology and therapeutics 2020 Oct . Puszkiel Alicja, Arellano Cécile, Vachoux Christelle, Evrard Alexandre, Le Morvan Valérie, Boyer Jean-Christophe, Robert Jacques, Delmas Caroline, Dalenc Florence, Debled Marc, Venat-Bouvet Laurence, Jacot William, Dohollou Nadine, Bernard-Marty Chantal, Laharie-Mineur Hortense, Filleron Thomas, Roché Henri, Chatelut Etienne, Thomas Fabienne, White-Koning Melan |
| Pharmacogenetics of Risperidone-Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder. Basic & clinical pharmacology & toxicology 2018 Jan . Sukasem Chonlaphat, Vanwong Natchaya, Srisawasdi Pornpen, Ngamsamut Nattawat, Nuntamool Nopphadol, Hongkaew Yaowaluck, Puangpetch Apichaya, Chamkrachangpada Bhunnada, Limsila Penkh |
| Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms. Annals of clinical biochemistry 2016 Dec . Akamine Yumiko, Sugawara-Kikuchi Yuka, Uno Tsukasa, Shimizu Tetsuo, Miura Masato |
| Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis. Pharmacogenetics and genomics 2016 May . Nishimura Miki, Ueda Mikito, Saruwatari Junji, Nakashima Hiroo, Ogusu Naoki, Aoki Akiko, Tsuchimine Shoko, Matsuda Kazuki, Iwashita Kazuma, Ono Tatsumasa, Oniki Kentaro, Shimoda Kazutaka, Yasui-Furukori Nor |
| Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain. Fundamental & clinical pharmacology 2016 Apr 30 (2): 153-61. de Moraes Natália V, Lauretti Gabriela R, Coelho Eduardo B, Godoy Ana Leonor P C, Neves Daniel V, Lanchote Vera |
| Factors Affecting Steady-state Plasma Concentrations of Enantiomeric Mirtazapine and its Desmethylated Metabolites in Japanese Psychiatric Patients. Pharmacopsychiatry 2015 Nov 48 (7): 279-85. Hayashi Y, Watanabe T, Aoki A, Ishiguro S, Ueda M, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda |
| Fast Versus Slow Strategy of Switching Patients With Schizophrenia to Aripiprazole From Other Antipsychotics. Journal of clinical psychopharmacology 2015 Oct . Hwang Tzung-Jeng, Lo Wei-Ming, Chan Hung-Yu, Lin Ching-Feng, Hsieh Ming H, Liu Chen-Chun, Liu Chih-Min, Hwu Hai-Gwo, Kuo Ching-Hua, Chen Wei |
| Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity. Drug metabolism and pharmacokinetics 2015 Aug 30 (4): 257-62. Doki Kosuke, Sekiguchi Yukio, Kuga Keisuke, Aonuma Kazutaka, Homma Masa |
| Association study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment response. Journal of clinical psychopharmacology 2012 Aug 32 (4): 441-8. Lee Seung-Tae, Ryu Seunghyong, Kim Suk-Ran, Kim Min-Ji, Kim Seonwoo, Kim Jong-Won, Lee Soo-Youn, Hong Kyung S |
| CYP2D6 genotype affects age-related decline in flecainide clearance: a population pharmacokinetic analysis. Pharmacogenetics and genomics 2012 Aug . Doki K, Homma M, Kuga K, Aonuma K, Kohda Y |
| Population pharmacokinetics of R- and S-carvedilol in Japanese patients with chronic heart failure. Biological & pharmaceutical bulletin 2010 33 (8): 1378-84. Saito Masako, Kawana Junichi, Ohno Tetsuro, Hanada Kazuhiko, Kaneko Masahiro, Mihara Kiyoshi, Shiomi Mari, Nagayama Masatoshi, Sumiyoshi Tetsuya, Ogata Hiroya |
| Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients. European journal of clinical pharmacology 2006 Sep 62 (9): 721-6. Varsaldi Federica, Miglio Gianluca, Scordo Maria Gabriella, Dahl Marja-Liisa, Villa Laura Maria, Biolcati Aldo, Lombardi Graz |
| Risperidone-related weight gain: genetic and nongenetic predictors. Journal of clinical psychopharmacology 2006 Apr 26 (2): 128-34. Lane Hsien-Yuan, Liu Yi-Ching, Huang Chieh-Liang, Chang Yue-Cune, Wu Po-Lun, Lu Chung-Ta, Chang Wen- |
| Effects of smoking and cytochrome P450 2D6*10 allele on the plasma haloperidol concentration/dose ratio. Progress in neuro-psychopharmacology & biological psychiatry 2003 Sep 27 (6): 945-9. Ohara Koichi, Tanabu Shigeru, Yoshida Kimiko, Ishibashi Kazuhisa, Ikemoto Keiko, Shibuya Har |
| Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia. Therapeutic drug monitoring 2003 Jun 25 (3): 287-93. Mihara Kazuo, Kondo Tsuyoshi, Yasui-Furukori Norio, Suzuki Akihito, Ishida Masayuki, Ono Shingo, Kubota Takahiro, Iga Tatsuji, Takarada Yutaka, de Vries Ronald, Kaneko Sun |
| Effects of age and the CYP2D6*10 allele on the plasma haloperidol concentration/dose ratio. Progress in neuro-psychopharmacology & biological psychiatry 2003 May 27 (3): 347-50. Ohara Koichi, Tanabu Shigeru, Ishibashi Kazuhisa, Ikemoto Keiko, Yoshida Kimiko, Shibuya Har |
| CYP2D6*10 alleles do not determine plasma fluvoxamine concentration/dose ratio in Japanese subjects. European journal of clinical pharmacology 2003 Feb 58 (10): 659-61. Ohara Koichi, Tanabu Shigeru, Ishibashi Kazuhisa, Ikemoto Keiko, Yoshida Kimiko, Shibuya Har |
| The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment. Clinical pharmacology and therapeutics 2002 Oct 72 (4): 438-52. Brockmöller Jürgen, Kirchheiner Julia, Schmider Jürgen, Walter Silke, Sachse Christoph, Müller-Oerlinghausen Bruno, Roots Iv |
| The impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients. Journal of clinical psychopharmacology 2002 Aug 22 (4): 371-8. Shimoda Kazutaka, Someya Toshiyuki, Yokono Aya, Morita Sachiyo, Hirokane Genta, Takahashi Saburo, Okawa Masa |
| The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients. Journal of clinical psychopharmacology 2001 Dec 21 (6): 549-55. Yokono A, Morita S, Someya T, Hirokane G, Okawa M, Shimoda |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 12, 2022
- Content source: